Cappella Completes First Tranche of €10.5M Series D Investment
Cappella, Inc., a Dover, Del.- and Galway, Ireland-based medical device company that is developing novel solutions for the treatment of Complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease, has completed the first tranche of a €10.5m Series D equity and debt financing. Equity investors include existing backers Polytechnos Partners, ACT Venture Capital, Fountain […]